Dr. Robert G. Bristow

Ontario Cancer Institute/Princess Margaret Hospital, Toronto, Canada

Dr. Bristow is a Clinician-Scientist and Professor within the Departments of Radiation Oncology and Medical Biophysics at the University of Toronto and the Ontario Cancer Institute/Princess Margaret Hospital (UHN). His current research focuses on personalised medicine approaches to prostate cancer treatment based on DNA repair, tumour hypoxia and genomics.

Dr. Bristow is currently Co-Director of the STTARR Innovation Facility, Head of the PMH-CFCRI Prostate Cancer Research Program and Lead PI for the Canadian Prostate Cancer Genome Sequencing Project. He has over 200 published papers, abstracts and book chapters and has been an Invited Speaker or Visiting Professor on more than 100 occasions. He is a Canadian Cancer Society Career Research Scientist, an Honorary Fellow of the European Society of Therapeutic Radiation Oncology, and twice an awardee of the Canadian Foundation of Innovation (CFI).